$72.42+3.00% (+$2.13)XNAS · the security, not a token
Loading the security overview…
Where the tokens are
Peers
10 of 14 have tokenized versionsFirst the companies classified under the same themes, most themes in common first; then the ones investors most often look at alongside WGS. A peer with a tokenized version links to its own page, where every issuer that wraps it is listed.
| Company | Shared themes | Market cap | P/E | P/S | EV/EBITDA | ROE | F-Score | Altman zone |
|---|---|---|---|---|---|---|---|---|
 WGSThis companyGeneDx Holdings Corp. Class A Common Stock | — | $2.12B | — | 4.7 | -62.9 | −43.6% | 5/9 | distress |
 CDNACareDx, Inc. | Genetic Testing & DiagnosticsPrecision Medicine Platforms | $3.43B | 30.9 | 7.5 | 300.0 | 26.1% | 5/9 | safe |
 AZNTokenizedAstraZeneca PLC | Precision Medicine Platforms | $244.58B | 110.1 | 10.2 | 48.8 | 16.4% | 8/9 | safe |
 TMOTokenizedThermo Fisher Scientific, Inc. | Precision Medicine Platforms | $241.26B | 34.6 | 5.2 | 24.6 | 13.2% | 6/9 | safe |
 DHRTokenizedDanaher Corporation | Precision Medicine Platforms | $148.86B | 37.2 | 5.9 | 22.3 | 7.6% | 6/9 | safe |
 NTRATokenizedNatera, Inc. Common Stock | Genetic Testing & Diagnostics | $58.88B | — | 21.8 | -256.5 | −10.6% | 3/9 | safe |
 WATTokenizedWaters Corp | Precision Medicine Platforms | $41.81B | 251.6 | 9.0 | 83.5 | 1.1% | 5/9 | safe |
 ILMNTokenizedIllumina Inc | Genetic Testing & Diagnostics | $40.12B | 48.6 | 8.9 | 36.5 | 29.1% | 7/9 | safe |
 LHLabcorp Holdings Inc. | Genetic Testing & Diagnostics | $24.7B | 24.6 | 1.7 | 13.1 | 11.7% | 8/9 | safe |
 GHTokenizedGuardant Health, Inc. Common Stock | Precision Medicine Platforms | $23.45B | — | 19.8 | -55.4 | 203.5% | 3/9 | safe |
 TEMTokenizedTempus AI, Inc. Class A Common Stock | Precision Medicine Platforms | $13.89B | — | 9.7 | -114.0 | −57.2% | 3/9 | safe |
 BBIOTokenizedBridgeBio Pharma, Inc. Common Stock | Precision Medicine Platforms | $13.08B | — | 18.3 | -31.5 | 27.5% | 2/9 | distress |
 TWSTTokenizedTwist Bioscience Corporation Common Stock | Precision Medicine Platforms | $12.47B | — | 28.9 | -110.0 | −30.7% | 3/9 | safe |
 TXG10x Genomics, Inc. Class A Common Stock | Genetic Testing & Diagnostics | $11.56B | — | 18.8 | -213.6 | −9.1% | 3/9 | safe |
 NUVLNuvalent, Inc. Class A Common Stock | Precision Medicine Platforms | $9.81B | — | — | -22.0 | −38.3% | 1/9 | safe |
Figures describe GeneDx shares, not any token. From theme classifications, Massive's related companies and the latest ratios and scores. Ratios are trailing, each as of its own latest filing. Peers are for comparison, not a list of alternatives to buy.